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To study the effect of cell-to-cell movement of potato virus X (PVX) on the size-exclusion limit of plasmodesmata we have
microinjected virus particles and fluorescently labelled dextrans (F-dextrans) with average molecular mass of 4.4, 10, and
20 kDa into Nicotiana clevelandii trichome cells. A vector construct of PVX expressing GUS (PVX.GUS) moved from the
injected cell and modified the plasmodesmata to allow passage of the 4.4- and 10-kDa F-dextrans but not the 20-kDa F-
dextran. A mutant PVX with a deletion in the gene for the 25-kDa protein accumulated in inoculated protoplasts to the same
level as the wild-type PVX. This mutant virus did not move from the injected cell and did not modify the plasmodesmata to
allow passage of the 10-kDa F-dextran. However, the 4.4-kDa F-dextran moved from the cells infected with the mutant
virus. These data therefore illustrate that movement of PVX is associated with modification of plasmodesmata. The full
plasmodesmatal modification requires a functional 25-kDa protein but partial modification occurs when this protein is
present in a mutant form. q 1996 Academic Press, Inc.
The movement proteins of many viruses [e.g., those of sequence and an ApaI site located at nucleotide position
4945 in the PVX sequence. The mutation was introducedtobacco mosaic virus (TMV) (1– 5), red clover necrotic
into the infectious cDNA clone of PVX, pTXS, to generatemosaic virus (RCNMV) (6), alfalfa mosaic virus (AMV) (7),
pTXSDApa/Apa (Fig. 1). Construct pGC3DApa/Apa hadcucumber mosaic virus (CMV) (8, 9), tobacco rattle virus
the same mutation in the PVX.GUS genome (Fig. 1).(TRV) (10), and bean dwarf mosaic geminivirus (BDMV)
PVX.GUS was fully infectious when inoculated onto(11)] increase the size-exclusion limit (SEL) of plasmo-
Nicotiana clevelandii and N. tabacum cv. Samsun NN,desmata. Here, we investigated whether the cell-to-cell
as described previously (12): symptoms developed, viralmovement of potato virus X (PVX) is also associated with
RNA accumulated in the inoculated and systemic leaves,an increase in the SEL of plasmodesmata. Changes in
and there was a high level of GUS activity in the infectedthe SEL were analysed using large fluorescently labelled
tissue. In contrast, after inoculation of N. clevelandii anddextrans (F-dextrans), which are usually unable to move
N. tabacum cv. Samsun NN with transcripts ofbetween noninfected cells.
pTXSDApa/Apa or pGC3DApa/Apa, we failed to detectIn this study we have used PVX.GUS and a PVX.GUS
accumulation of viral RNA by gel blot analysis on themutant that was not competent to move between cells.
inoculated or systemic leaves (C. Davies and P. Etes-PVX.GUS is a previously described (12) derivative of PVX
sami, unpublished data). GUS activity was restricted toexpressing the b-glucuronidase gene (GUS) (Fig. 1).
small regions on the inoculated leaf, indicating that theWhen microinjected into trichomes, PVX.GUS moved be-
mutant virus was restricted to the inoculated cells ortween trichome cells and entered the leaf margin (13).
small clusters of cells adjacent to the inoculated cellsThe PVX.GUS mutant contained an in-frame deletion in
(data not shown).the first open reading frame of the ‘‘triple gene block’’
The reduced accumulation and spread of the mutant(TGB) (encoding the 25-kDa protein) (Fig. 1). The TGB
PVX was not due to defective replication because tran-proteins of PVX and of the related virus, white clover
scripts of pTXS and pTXSDApa/Apa inoculated onto N.mosaic virus, are essential for virus movement [C. Davies
tabacum cv. Samsun NN protoplasts produced similarand P. Etessami, unpublished data; (14)]. The deletion
levels of viral RNA at 24 hr postinoculation. The RNA gelextended between nucleotide position 4587 in the PVX
blot analysis (Fig. 2) shows these data for the genomic
and subgenomic RNAs. A probe specific for the negative-1 Present address: CSIRO, Division of Horticulture, G.P.O. Box 350,
strand RNA also showed that the mutation had no effectAdelaide, South Australia 5001, Australia.
on viral RNA accumulation (data not shown).2 To whom correspondence and reprint requests should be ad-
dressed. Fax: /44 1603 250024. In preliminary microinjection studies we found that in-
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out of the injected cell within 24 hr. In contrast, when
PVX107 virions were injected (36 injections), GUS activity
was detected only in the injected cell (at 24 hr postinjec-
tion), showing that the mutant virus could replicate but
not move between cells. The GUS activity was still con-
fined to the PVX107-injected cell at 5 days postinjection
(Fig. 3A), demonstrating that there was complete lack of
cell-to-cell movement of this mutant virus.
To determine whether cell-to-cell movement of PVX
was associated with a change in the SEL of plasmodes-FIG. 1. Open reading frame organisation of the PVX constructs. The
diagrams represent the 3* genome organisation of the PVX constructs mata, the trichome cells of N. clevelandii were injected
used in these experiments. The various open reading frames (orfs) are with F-dextran (average molecular mass 10 kDa) and
labelled: 25, 12, 8, the ‘‘triple gene block’’ genes (encoding proteins sulforhodamine B either with PVX.GUS or PVX107 or with-of 25, 12, and 8 kDa, respectively); CP, coat protein gene; GUS, b-
out virus. The replication of PVX (and movement ofglucuronidase gene. The open box at the left side of each map repre-
PVX.GUS) was confirmed by histochemical staining forsents the 3* part of orf 1 which encodes the RNA-dependent RNA
polymerase. The orfs are carried in cDNA constructs: pTXS, full-length GUS activity at 24 hr postinjection. The movement of the
infectious cDNA clone of PVX; pTXSDApa/Apa, a mutant derivative of 10-kDa F-dextran was also assessed at 24 hr postinjec-
pTXS with a 354-bp deletion (118 amino acids) within the 25-kDa gene;
tion. We included an a-1,6-glucosidase inhibitor, casta-pGC3, a cDNA clone of PVX expressing the b-glucuronidase gene from
nospermine (10 mg ml01), in the injection mix to preventa duplicated coat protein subgenomic promoter (12); pGC3DApa/Apa,
degradation of the F-dextran during this relatively longthe triple gene block mutation in the pGC3 genome. PVX.GUS and
PVX107 are the names of the viruses that were derived from the cDNA incubation period. In the absence of the inhibitor there
clones pGC3 and pGC3DApa/Apa, respectively. The shaded regions was movement of the F-dextran even in the absence of
represent the mutated 25-kDa triple gene block gene. The sequence virus (in 14 of 16 injections). In contrast, in the presenceat genome nucleotide position 4582 in the wild-type 25-kDa gene is
of the inhibitor only 2 of 19 injections showed movementshown to the right of the map of pTXS. The mutant was generated by
of the F-dextran in the absence of virus. GUS activitydeletion between an ApaI site (introduced by mutation of nucleotides
4588–4591 in the PVX genome) and an ApaI site existing naturally was always detected in the PVX-infected cells at 24 hr
at position 4945. The modification to the PVX sequence at genome postinjection irrespective of whether castanospermine
nucleotide position 4588 in the mutant construct is shown to the right was included in the injection mix or not, indicating thatof the map for pTXSDApa/Apa.
the inhibitor had no effect on the replication and move-
ment of PVX. With castanospermine in the injection mix,
movement of the 10-kDa F-dextran occurred in 9 of 18fection of trichome cells was more reproducible using
virions rather than a viral RNA inoculum. The microinjec- injections from the PVX.GUS-infected cells and in 2 of 11
tion experiments described below are therefore all based
on virion inocula. The PVX.GUS virions were prepared
from infected N. clevelandii plants, whereas the mutant
virions (referred to hereafter as PVX107) were prepared
from N. tabacum cv. Petite Havana plants carrying a
transgene construct in which the pGC3DApa/Apa se-
quence was inserted between the cauliflower mosaic
virus 35S promoter and the nos terminator. The yield of
mutant virions from these plants was similar to that of
wild-type virus in infected plants (S. Angell, unpublished
data).
The preparation of virions, microinjection procedure,
incubation of injected leaves, and assays for GUS activity
FIG. 2. RNA gel blot analysis of RNA from N. tabacum cv. Samsunwere performed as described previously (13). The data
NN protoplasts 24 hr after inoculation with PVX transcripts. The totalpresented here are based only on those injections where
RNA extracted from 50,000 protoplasts was fractionated on a 0.9%the control dye, sulforhodamine B (581 Da) entered the
(w/v) agarose–formaldehyde gel, blotted to a nylon membrane, and
cytoplasm and moved into adjacent cells within a few hybridised to an RNA probe specific for the 3* end of the positive
minutes after injection. Virus replication and move- strand of PVX. Hybridisation and probe synthesis were performed as
described previously (12). The inocula for the samples were transcriptsment were assessed by histochemical staining for GUS
of pTXS in lanes 1 and 2, mock inoculated in lane 3, and transcriptsactivity.
of pTXSDApa/Apa in lanes 4 and 5. The lanes 1 and 2 or 4 and 5 areIn a previous report (13) we monitored movement of
each extracts of duplicate protoplast samples inoculated with the same
PVX.GUS at 5 days postinjection. Here we observed GUS amount of RNA. The autoradiograph was exposed for 4 hr and the
activity in the injected and adjacent cells at 24 hr postin- arrows indicate the position of genomic RNA and subgenomic RNAs
(the asterisk denotes the genomic RNA).jection, indicating that PVX.GUS replicated and moved
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FIG. 3. Microinjection of N. clevelandii trichome cells. (A). Histochemical analysis of GUS activity in trichome cells 5 days after microinjection
with PVX107 virions. The arrow points to the injected cell. GUS activity was confined to the injected cell, indicating that the mutant virus was unable
to undergo cell-to-cell movement. (B). Microinjection of 10-kDa F-dextran into a trichome cell which had been injected 8 hr previously with the
control dye, sulforhodamine B. Fluorescence is confined to the injected cell, indicating that the 10-kDa F-dextran was unable to move out of the
noninfected cell. (C). Microinjection of 10-kDa F-dextran into trichome cell 1 which had been injected 8 hr previously with the control dye and
PVX.GUS virions (see Ref. (13) for numbering system for trichome cells). Fluorescence has moved into cells 2, 3, and 4. (D). Histochemical analysis
of GUS activity in the trichome shown in C. GUS staining was performed 24 hr after microinjection of cell 1 with sulforhodamine B, 10-kDa F-
dextran, and PVX.GUS virions. The blue GUS reaction product is not visible in cells 3, 4, and 5, indicating that the 10-kDa F-dextran had moved
beyond the cells in which PVX replication was detected. The faint blue staining in cell 3 was attributed to diffusion of the GUS reaction product.
The slight differences in the shape and size of the trichome image in plates C and D are because the sample was photographed at different
magnifications. Also, the image in plate D is slightly distorted due to vacuum infiltration of the trichome with GUS staining solution and the
subsequent photography was performed with the trichome under liquid. The differences in the background colour of plates A and D are because
the trichomes were photographed using different filter sets on the microscope.
injections from cells infected with PVX107 virions. We 8 to 10 hr after injection 1 (Table 1). There was no move-
ment of the 10-kDa F-dextran when injection 2 was car-therefore conclude that there was an increase in plasmo-
desmatal SEL associated with movement of PVX. ried out 5 to 6 hr after injection 1 (no movement from 5
injections), indicating that PVX.GUS required a minimumThe increase in the SEL of plasmodesmata associated
with movement of PVX was further characterised with of 6 to 8 hr to replicate, synthesize movement proteins,
and increase the SEL of plasmodesmata. This period ofF-dextrans of different sizes. The trichome cells were
injected first with virions and sulforhodamine B (injection time required to move across one cell boundary is similar
to that reported for TRV virions (10). In each instance we1) and later with the F-dextran (injection 2). In the
PVX.GUS-infected cells, there was movement of 10-kDa confirmed by histochemical analysis for GUS activity that
PVX had moved from the injected cell. In the PVX107-F-dextran within 1 to 3 min if injection 2 was performed
/ m4950f7687 01-04-96 13:16:16 vira AP-Virology
200 SHORT COMMUNICATION
TABLE 1 consistent with previous reports that viral movement pro-
teins are capable of moving between cells (6, 9, 11).Movement of F-Dextrans in PVX-Infected and in Noninfected
The main conclusion from this work is that movementTobacco Trichome Cells
of PVX, like that of TMV, TRV, CMV, AMV, RCNMV, and
No virusa PVX.GUSa,b PVX107a,b BDMV, is associated with a plasmodesmatal modifica-
tion that was manifested as an increase in the SEL. The
4.4-kDa F-dextranc 6/18 (33%)d 9/13 (69%) 9/11 (82%) increase in SEL was not sufficient to allow movement of10-kDa F-dextranc 1/22 (5%) 12/14 (86%) 2/10 (20%)
20-kDa F-dextran (3.1-nm Stokes radius), indicating that,20-kDa F-dextranc 0/10 (0%) 0/10 (0%) Not tested
although the coat protein is essential for movement of
a The trichome cells were injected with sulforhodamine B with or PVX (12, 15), the viral RNA may not move as virions (width
without virus. 8 to 10 hr after the first injection the cells were reinjected 11 nm). The modification to plasmodesmata associated
with F-dextran. The movement of F-dextran was monitored for a period
with cell-to-cell movement of PVX is functionally similarof 20 min. The control dye (sulforhodamine B) entered the cytoplasm
to that observed with the TMV movement protein [whenand moved into adjacent cells within 1 to 3 min after injection.
b The virus was included in the injection mix at 2.5– 5.0 mg ml01. expressed transgenically (2)] and with purified BDMV
Estimated injection volume was 1 pl. The presence of GUS activity in movement protein (11). However, we cannot necessarily
the injected cell confirmed that PVX had synthesized subgenomic conclude that PVX moves in the same way as these other
RNAs. GUS activity in the adjacent cells confirmed that PVX.GUS had
viruses. The increase in the SEL of plasmodesmata mightmoved.
result from a change in the outer diameter of the plasmo-c F-dextrans with an average molecular mass of 4.4 kDa (Sigma), 10
kDa (Molecular Probes), and 20 kDa (Molecular Probes) were prepared desmatal channel, a reduction in the appressed endo-
using Centricon concentrators (Amicon) with the appropriate mem- plasmic reticulum passing through the plasmodesmata,
brane molecular mass cutoff. The absence of free fluorescein in the or a change in the arrangement of the proteins that form
F-dextran preparations was confirmed by thin-layer chromatography
the microchannels.using the solvent system CHCl3/MeOH/CH3CO2H in the proportions
We also cannot conclude that the 25-kDa protein is70/25/5. The F-dextrans were injected at a concentration of 2 mM.
d The number of injections resulting in movement of fluorescently directly and solely responsible for the plasmodesmatal
labelled dextran (F-dextran)/the total number of successful injections. modification, as proposed for the movement proteins of
The percentage of injections resulting in movement of F-dextran are TMV, TRV, CMV, AMV, RCNMV, and BDMV. Indeed, it is
given in parentheses.
likely that other PVX-encoded proteins can increase the
SEL of plasmodesmata because there was enhanced
movement of the 4.4-kDa F-dextran from PVX107-infected
infected cells, as in the single injection experiments,
cells. The primary location of the 25-kDa protein is in
there was no movement of virus and the 10-kDa F-dex- lamellar inclusion structures (16) which is also consistent
tran moved at a low frequency (Table 1). with the notion that this protein does not directly modify
In similar experiments a 20-kDa F-dextran failed to plasmodesmata. If other PVX-encoded proteins are re-
move from cells infected with PVX.GUS (Table 1). The sponsible for plasmodesmatal moification it is likely that
PVX.GUS therefore altered the plasmodesmata to allow they would be the 12- and 8-kDa proteins encoded in
passage of molecules with a Stokes radius of between the TGB. Sequence analyses revealed that both of these
2.3 (the 10-kDa F-dextran) and 3.1 nm (the 20-kDa F- proteins possess highly hydrophobic domains, sug-
dextran). In contrast a 4.4-kDa F-dextran moved from the gesting that they may be associated with membranes
injected cell either in the absence or the presence of (17, 18). Moreover, in vitro translation of these two TGB
PVX although there was movement of this small dextran proteins from PVX showed that they both have a high
from more of the PVX.GUS- or PVX107-infected cells than affinity to membranes (19), which is consistent with the
from the noninfected cells (Table 1). It is therefore likely suggestion that they may interact with plasmodesmata.
that the SEL in noninfected trichomes is close to the size
of the 4.4-kDa F-dextran and that it was increased in
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